{
  "success": true,
  "pagesUsed": [
    5,
    12,
    16
  ],
  "modelUsed": "gemini-3-flash-preview",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "Title Page",
        "text": "Title Page",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1.0",
        "sectionTitle": "Title Page",
        "sectionType": {
          "id": "38405719-06ba-4bcd-8085-11b6813a0fa8",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_2",
        "name": "Protocol Amendment: Summary of Changes",
        "text": "Protocol Amendment: Summary of Changes",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1.1",
        "sectionTitle": "Protocol Amendment: Summary of Changes",
        "sectionType": {
          "id": "7b2779ed-9cdf-4806-bedf-e79737d7a2d9",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_3",
        "name": "Synopsis",
        "text": "Synopsis",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1.2",
        "sectionTitle": "Synopsis",
        "sectionType": {
          "id": "586f17e2-0886-4781-82cb-ebd25f481c43",
          "code": "Synopsis",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Synopsis",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_4",
        "name": "List of Abbreviations and Definition of Terms",
        "text": "List of Abbreviations and Definition of Terms",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1.3",
        "sectionTitle": "List of Abbreviations and Definition of Terms",
        "sectionType": {
          "id": "3ecb8d13-0edc-44fc-89c1-aa1ab0c64dd5",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_5",
        "name": "Table of Contents",
        "text": "Table of Contents",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2.0",
        "sectionTitle": "Table of Contents",
        "sectionType": {
          "id": "b8314a9f-9395-4f66-8e54-8844f495ce81",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_6",
        "name": "Introduction",
        "text": "Introduction",
        "order": 5,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3.0",
        "sectionTitle": "Introduction",
        "sectionType": {
          "id": "b67d6c6f-4bc3-413e-93bf-e89fa1f5c824",
          "code": "Introduction",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Introduction",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_6_1",
          "nci_6_2",
          "nci_6_3",
          "nci_6_4",
          "nci_6_5",
          "nci_6_6"
        ]
      },
      {
        "id": "nc_7",
        "name": "Study Objectives",
        "text": "Study Objectives",
        "order": 6,
        "instanceType": "NarrativeContent",
        "sectionNumber": "4.0",
        "sectionTitle": "Study Objectives",
        "sectionType": {
          "id": "1c4a3b92-e241-4ada-a24b-18a270c7dbe4",
          "code": "Objectives",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Objectives",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_8",
        "name": "Investigational Plan",
        "text": "Investigational Plan",
        "order": 7,
        "instanceType": "NarrativeContent",
        "sectionNumber": "5.0",
        "sectionTitle": "Investigational Plan",
        "sectionType": {
          "id": "1bca6778-bbe0-49ce-b984-8e301f26f7ec",
          "code": "Study Design",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Design",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_8_1",
          "nci_8_2",
          "nci_8_3"
        ]
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_6_1",
        "name": "Breast Cancer",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.1",
        "sectionTitle": "Breast Cancer"
      },
      {
        "id": "nci_6_2",
        "name": "Carboplatin and Paclitaxel",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.2",
        "sectionTitle": "Carboplatin and Paclitaxel"
      },
      {
        "id": "nci_6_3",
        "name": "Poly(ADP-ribose)-Polymerase (PARP) Mechanism of Action",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.3",
        "sectionTitle": "Poly(ADP-ribose)-Polymerase (PARP) Mechanism of Action"
      },
      {
        "id": "nci_6_4",
        "name": "Veliparib",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.4",
        "sectionTitle": "Veliparib"
      },
      {
        "id": "nci_6_5",
        "name": "Benefits and Risks",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.5",
        "sectionTitle": "Benefits and Risks"
      },
      {
        "id": "nci_6_6",
        "name": "Differences Statement",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.6",
        "sectionTitle": "Differences Statement"
      },
      {
        "id": "nci_8_1",
        "name": "Overall Study Design and Plan: Description",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.1",
        "sectionTitle": "Overall Study Design and Plan: Description"
      },
      {
        "id": "nci_8_2",
        "name": "Selection of Study Population",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.2",
        "sectionTitle": "Selection of Study Population"
      },
      {
        "id": "nci_8_3",
        "name": "Efficacy Pharmacokinetic, Biomarker, Exploratory Research and Safety Assessments/Variables",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.3",
        "sectionTitle": "Efficacy Pharmacokinetic, Biomarker, Exploratory Research and Safety Assessments/Variables"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "PARP",
        "expandedText": "Poly(ADP-ribose)-Polymerase",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "PFS",
        "expandedText": "progression-free survival",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "C",
        "expandedText": "carboplatin",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "P",
        "expandedText": "paclitaxel",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "OS",
        "expandedText": "overall survival",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "CBR",
        "expandedText": "clinical benefit rate",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "ORR",
        "expandedText": "objective response rate",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "PFS2",
        "expandedText": "progression-free survival 2",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_9",
        "abbreviatedText": "DOR",
        "expandedText": "duration of overall response",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_10",
        "abbreviatedText": "ECOG",
        "expandedText": "Eastern Cooperative Oncology Group",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_11",
        "abbreviatedText": "QoL",
        "expandedText": "Quality of Life",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_12",
        "abbreviatedText": "ER",
        "expandedText": "estrogen receptor",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_13",
        "abbreviatedText": "PR",
        "expandedText": "progesterone receptor",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_14",
        "abbreviatedText": "PgR",
        "expandedText": "progesterone receptor",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_15",
        "abbreviatedText": "AUC",
        "expandedText": "Area Under the Curve",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_16",
        "abbreviatedText": "CNS",
        "expandedText": "central nervous system",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_17",
        "abbreviatedText": "NCCN",
        "expandedText": "National Comprehensive Cancer Network",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_18",
        "abbreviatedText": "PD",
        "expandedText": "progressive disease",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_19",
        "abbreviatedText": "RECIST 1.1",
        "expandedText": "Response Evaluation Criteria in Solid Tumors version 1.1",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_20",
        "abbreviatedText": "ADP",
        "expandedText": "Adenosine Diphosphate",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_21",
        "abbreviatedText": "AE",
        "expandedText": "Adverse Event",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_22",
        "abbreviatedText": "AI",
        "expandedText": "Aromatase Inhibitor",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_23",
        "abbreviatedText": "ALT",
        "expandedText": "Alanine Transaminase",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_24",
        "abbreviatedText": "ANC",
        "expandedText": "Absolute Neutrophil Count",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_25",
        "abbreviatedText": "ANCOVA",
        "expandedText": "Analysis of Covariance",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_26",
        "abbreviatedText": "APTT",
        "expandedText": "Activated Partial Thromboplastin Time",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_27",
        "abbreviatedText": "ASCO",
        "expandedText": "American Society of Clinical Oncology",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_28",
        "abbreviatedText": "AST",
        "expandedText": "Aspartate Aminotransferase",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_29",
        "abbreviatedText": "BC",
        "expandedText": "Breast Cancer",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_30",
        "abbreviatedText": "BCNU",
        "expandedText": "Trade name for Carmustine",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_31",
        "abbreviatedText": "BID",
        "expandedText": "Twice a Day",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_32",
        "abbreviatedText": "BSA",
        "expandedText": "Body Surface Area",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_33",
        "abbreviatedText": "BPI-SF",
        "expandedText": "Brief Pain Inventory – Short Form",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_34",
        "abbreviatedText": "BRCA",
        "expandedText": "Breast Cancer Gene",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_35",
        "abbreviatedText": "BUN",
        "expandedText": "Blood Urea Nitrogen",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_36",
        "abbreviatedText": "CBC",
        "expandedText": "Complete Blood Count",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_37",
        "abbreviatedText": "CFR",
        "expandedText": "Code of Federal Regulations",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_38",
        "abbreviatedText": "CMH",
        "expandedText": "Cochran-Mantel-Haenszel",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_39",
        "abbreviatedText": "CLIA",
        "expandedText": "Clinical Laboratory Improvement Amendments",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_40",
        "abbreviatedText": "CPT",
        "expandedText": "Cell Preparation Tube",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_41",
        "abbreviatedText": "CR",
        "expandedText": "Complete Response",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_42",
        "abbreviatedText": "CRF",
        "expandedText": "Case Report Form",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_43",
        "abbreviatedText": "eCRF",
        "expandedText": "Electronic Case Report Form",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_44",
        "abbreviatedText": "CRO",
        "expandedText": "Contract Research Organization",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_45",
        "abbreviatedText": "CSR",
        "expandedText": "Clinical Study Report",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_46",
        "abbreviatedText": "CT",
        "expandedText": "Computed Tomography",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_47",
        "abbreviatedText": "CTC",
        "expandedText": "Circulating Tumor Cells",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_48",
        "abbreviatedText": "CTEP",
        "expandedText": "Cancer Therapy Evaluation Program",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_49",
        "abbreviatedText": "CV",
        "expandedText": "Cardiovascular",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 8,
      "itemCount": 9,
      "abbreviationCount": 49
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "A Phase 3 Randomized Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the PARP Inhibitor Veliparib (ABT-888) in HER2-Negative Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "Amendment 4",
      "versionDate": "23 July 2020",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5",
        "nc_6",
        "nc_7",
        "nc_8"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "PARP",
          "expansion": "Poly(ADP-ribose)-Polymerase"
        },
        {
          "abbreviation": "PFS",
          "expansion": "progression-free survival"
        },
        {
          "abbreviation": "C",
          "expansion": "carboplatin"
        },
        {
          "abbreviation": "P",
          "expansion": "paclitaxel"
        },
        {
          "abbreviation": "OS",
          "expansion": "overall survival"
        },
        {
          "abbreviation": "CBR",
          "expansion": "clinical benefit rate"
        },
        {
          "abbreviation": "ORR",
          "expansion": "objective response rate"
        },
        {
          "abbreviation": "PFS2",
          "expansion": "progression-free survival 2"
        },
        {
          "abbreviation": "DOR",
          "expansion": "duration of overall response"
        },
        {
          "abbreviation": "ECOG",
          "expansion": "Eastern Cooperative Oncology Group"
        },
        {
          "abbreviation": "QoL",
          "expansion": "Quality of Life"
        },
        {
          "abbreviation": "ER",
          "expansion": "estrogen receptor"
        },
        {
          "abbreviation": "PR",
          "expansion": "progesterone receptor"
        },
        {
          "abbreviation": "PgR",
          "expansion": "progesterone receptor"
        },
        {
          "abbreviation": "AUC",
          "expansion": "Area Under the Curve"
        },
        {
          "abbreviation": "CNS",
          "expansion": "central nervous system"
        },
        {
          "abbreviation": "NCCN",
          "expansion": "National Comprehensive Cancer Network"
        },
        {
          "abbreviation": "PD",
          "expansion": "progressive disease"
        },
        {
          "abbreviation": "RECIST 1.1",
          "expansion": "Response Evaluation Criteria in Solid Tumors version 1.1"
        },
        {
          "abbreviation": "ADP",
          "expansion": "Adenosine Diphosphate"
        },
        {
          "abbreviation": "AE",
          "expansion": "Adverse Event"
        },
        {
          "abbreviation": "AI",
          "expansion": "Aromatase Inhibitor"
        },
        {
          "abbreviation": "ALT",
          "expansion": "Alanine Transaminase"
        },
        {
          "abbreviation": "ANC",
          "expansion": "Absolute Neutrophil Count"
        },
        {
          "abbreviation": "ANCOVA",
          "expansion": "Analysis of Covariance"
        },
        {
          "abbreviation": "APTT",
          "expansion": "Activated Partial Thromboplastin Time"
        },
        {
          "abbreviation": "ASCO",
          "expansion": "American Society of Clinical Oncology"
        },
        {
          "abbreviation": "AST",
          "expansion": "Aspartate Aminotransferase"
        },
        {
          "abbreviation": "BC",
          "expansion": "Breast Cancer"
        },
        {
          "abbreviation": "BCNU",
          "expansion": "Trade name for Carmustine"
        },
        {
          "abbreviation": "BID",
          "expansion": "Twice a Day"
        },
        {
          "abbreviation": "BSA",
          "expansion": "Body Surface Area"
        },
        {
          "abbreviation": "BPI-SF",
          "expansion": "Brief Pain Inventory – Short Form"
        },
        {
          "abbreviation": "BRCA",
          "expansion": "Breast Cancer Gene"
        },
        {
          "abbreviation": "BUN",
          "expansion": "Blood Urea Nitrogen"
        },
        {
          "abbreviation": "CBC",
          "expansion": "Complete Blood Count"
        },
        {
          "abbreviation": "CFR",
          "expansion": "Code of Federal Regulations"
        },
        {
          "abbreviation": "CMH",
          "expansion": "Cochran-Mantel-Haenszel"
        },
        {
          "abbreviation": "CLIA",
          "expansion": "Clinical Laboratory Improvement Amendments"
        },
        {
          "abbreviation": "CPT",
          "expansion": "Cell Preparation Tube"
        },
        {
          "abbreviation": "CR",
          "expansion": "Complete Response"
        },
        {
          "abbreviation": "CRF",
          "expansion": "Case Report Form"
        },
        {
          "abbreviation": "eCRF",
          "expansion": "Electronic Case Report Form"
        },
        {
          "abbreviation": "CRO",
          "expansion": "Contract Research Organization"
        },
        {
          "abbreviation": "CSR",
          "expansion": "Clinical Study Report"
        },
        {
          "abbreviation": "CT",
          "expansion": "Computed Tomography"
        },
        {
          "abbreviation": "CTC",
          "expansion": "Circulating Tumor Cells"
        },
        {
          "abbreviation": "CTEP",
          "expansion": "Cancer Therapy Evaluation Program"
        },
        {
          "abbreviation": "CV",
          "expansion": "Cardiovascular"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "A Phase 3 Randomized Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the PARP Inhibitor Veliparib (ABT-888) in HER2-Negative Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer",
        "version": "Amendment 4",
        "versionDate": "23 July 2020"
      },
      "sections": [
        {
          "number": "1.0",
          "title": "Title Page",
          "type": "Other"
        },
        {
          "number": "1.1",
          "title": "Protocol Amendment: Summary of Changes",
          "type": "Other"
        },
        {
          "number": "1.2",
          "title": "Synopsis",
          "type": "Synopsis"
        },
        {
          "number": "1.3",
          "title": "List of Abbreviations and Definition of Terms",
          "type": "Other"
        },
        {
          "number": "2.0",
          "title": "Table of Contents",
          "type": "Other"
        },
        {
          "number": "3.0",
          "title": "Introduction",
          "type": "Introduction",
          "subsections": [
            {
              "number": "3.1",
              "title": "Breast Cancer"
            },
            {
              "number": "3.2",
              "title": "Carboplatin and Paclitaxel"
            },
            {
              "number": "3.3",
              "title": "Poly(ADP-ribose)-Polymerase (PARP) Mechanism of Action"
            },
            {
              "number": "3.4",
              "title": "Veliparib",
              "subsections": [
                {
                  "number": "3.4.1",
                  "title": "Preclinical Experience"
                },
                {
                  "number": "3.4.2",
                  "title": "Clinical Experience"
                }
              ]
            },
            {
              "number": "3.5",
              "title": "Benefits and Risks"
            },
            {
              "number": "3.6",
              "title": "Differences Statement"
            }
          ]
        },
        {
          "number": "4.0",
          "title": "Study Objectives",
          "type": "Objectives"
        },
        {
          "number": "5.0",
          "title": "Investigational Plan",
          "type": "Study Design",
          "subsections": [
            {
              "number": "5.1",
              "title": "Overall Study Design and Plan: Description"
            },
            {
              "number": "5.2",
              "title": "Selection of Study Population",
              "subsections": [
                {
                  "number": "5.2.1",
                  "title": "Inclusion Criteria"
                },
                {
                  "number": "5.2.2",
                  "title": "Exclusion Criteria"
                },
                {
                  "number": "5.2.3",
                  "title": "Prior and Concomitant Therapy"
                }
              ]
            },
            {
              "number": "5.3",
              "title": "Efficacy Pharmacokinetic, Biomarker, Exploratory Research and Safety Assessments/Variables",
              "subsections": [
                {
                  "number": "5.3.1",
                  "title": "Efficacy and Safety Measurements Assessed and Flow Chart"
                }
              ]
            }
          ]
        }
      ]
    }
  }
}